Celltrion Healthcare Co., Ltd.
091990
Peringkat dalam Saham
#2142
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
Harga Saham
$57.75
Terakhir disinkronkan: 2024-01-11
Kapitalisasi Pasar
$9.42B
Perubahan (1 hari)
-0.25%
Perubahan (1 tahun)
0.00%
Negara
KR
Perdagangan Celltrion Healthcare Co., Ltd. (091990)
Kategori
Healthcare
Rasio P/S untuk Celltrion Healthcare Co., Ltd. (091990)
Rasio P/S per October 2026 TTM: 5.44
Menurut laporan keuangan dan harga saham terbaru dari Celltrion Healthcare Co., Ltd., rasio P/S saat ini (TTM) adalah 5.44. Pada akhir 2021, rasio P/S perusahaan adalah 7.25.
Riwayat rasio P/S untuk Celltrion Healthcare Co., Ltd. dari 2014 hingga 2026
Rasio P/S pada akhir setiap tahun
| Tahun | Rasio P/S | Mengubah |
|---|---|---|
| 2026 (TTM) | 5.44 | 16.07% |
| 2022 | 4.69 | -35.23% |
| 2021 | 7.25 | -17.28% |
| 2020 | 8.76 | -31.59% |
| 2019 | 12.81 | -35.25% |
| 2018 | 19.78 | 30.68% |
| 2017 | 15.14 | 12.59% |
| 2016 | 13.44 | -15.98% |
| 2015 | 16.00 | 9,049.06% |
| 2014 | 0.17 | 0.00% |
Rasio P/S untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/S | Perbedaan Rasio P/S | Negara |
|---|---|---|---|
| 10.02 | 84.10% |
US
|
|
| 40.55 | 644.89% |
US
|
|
| 4.19 | -23.02% |
AU
|
|
| 10.44 | 91.83% |
NL
|
|
| - | - |
CH
|
